Researchers from the National Cancer Institute reported they have successfully treated two patients with advanced cancer using gene therapy.

This is the first time genetically engineered immune-system cells — specifically, T lymphocytes — have produced that effect.

“I think it is an important landmark to see some cancer patients respond to a gene therapy — finally,” said Patrick Hwu, a physician and gene-therapy researcher at University of Texas M.D. Anderson Cancer Center.